Press release
View this email in your browser

Press Release

Double Bond Pharmaceutical joins hands with SMS-oncology for clinical development of SI-053
 
Uppsala, Sweden, and Schiphol, the Netherlands (09 Oct 2019) - Double Bond Pharmaceutical AS (“DBP”) announces today that Specialized Medical Services-oncology BV ("SMS-oncology") has been chosen for providing consultancy services to support the transition of their lead candidate, SI-053 from the preclinical phase to the clinical phase.

DBP’s strategy is to develop new medicines, thereby combining already known efficient approaches with their innovative first-in-class technologies to provide new therapeutic possibilities for the treatment of life-threatening diseases. Its lead compound...  Read more >
SMS-oncology is one of the few full-service contract research organizations (CROs) in the world solely dedicated to oncology. With our unique business model of integrating oncology drug development affairs and clinical operations, we cover the whole value chain from trial design to the setup, management, and completion of phase I to IV oncology trials. We specialize in early phase, pediatric and immuno-oncology trials.
Website
LinkedIn
Facebook
Twitter
Copyright © 2019 SMS-oncology BV, All rights reserved.


Our mailing address is:
info@sms-oncology.com

unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp